comparemela.com

Page 8 - Fluidigm Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Single Cell Analysis Market to record USD 3 16 Bn growth | North America to occupy 45% market share

/PRNewswire/ The single cell analysis market size is expected to increase by USD 3.16 bn from 2021 to 2026, registering a CAGR of 0.05% during the forecast.

United statesUnited kingdomAgilent technologies incBio techne corp0x genomics incNanostring technologies incCellchorus incMerck kgaTakara bio incRarecyte incBecton dickinsonFluidigm corpBio rad laboratories incMerck kgaaDanaher corpIllumina inc

Global Companion Diagnostic Markets Report 2022: Level of

Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with.

United statesPerkin elmerMiltenyi biotecSiemens healthineersQiagen gmbhSysmex inosticsBristol myers squibbCdx therascreenFoundation medicine testCastle biosciences incTechnology developmentSinglera genomics incEndpoint healthAstrazeneca strike ovarian cancer cdx allianceEnzo life sciences incBiodesix inc

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesHong kongSouth san franciscoCity ofUnited kingdomSan franciscoWilson sonsini goodrich rosatiLauram clagueEli casdinMartind madausMark spearmanNicolasm barthelemyCarlosv payaGerhardf burbachPeter denardo

Global Companion Diagnostic Markets Report 2022: Companion Diagnostics Bouncing Back from Pandemic as New Diagnostic Industry Comes into View

/PRNewswire/ The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19.

United statesMiltenyi biotecQiagen gmbhSysmex inosticsBristol myers squibbCdx therascreenPerkin elmerSiemens healthineersLaura woodFoundation medicine testCastle biosciences incTechnology developmentSinglera genomics incEndpoint healthAstrazeneca strike ovarian cancer cdx allianceEnzo life sciences inc

Global Companion Diagnostic Markets Report 2022: Companion Diagnostics Bouncing Back from Pandemic as New Diagnostic Industry Comes into View

/PRNewswire/ The "Companion Diagnostic Markets - the Future of Diagnostics, by Funding Source and Application with Customized Forecasting/Analysis, COVID-19.

United statesMiltenyi biotecQiagen gmbhSysmex inosticsBristol myers squibbCdx therascreenPerkin elmerSiemens healthineersLaura woodFoundation medicine testCastle biosciences incTechnology developmentSinglera genomics incEndpoint healthAstrazeneca strike ovarian cancer cdx allianceEnzo life sciences inc

vimarsana © 2020. All Rights Reserved.